Litecoin reserve company MEI Pharma renamed Litecoin Strategy

According to BlockBeats, on September 11, MEI Pharma, a litecoin reserve company listed on the US stock market, announced its name to be renamed Litecoin Strategy (Nasdaq: LITS). The company's stock price has risen 10.61% during the session, with its market value temporarily reported to US$101 million.